U.S. Senate Committee on Health,[...]
MAJORITY STAFF REPORT: Novo Nordisk’s Untenable Drug Pricing Strategy[...]
U.S. Senate Committee on Health,[...]
NEWS: Sanders Releases New Report, PBMs Welcome Lower List Prices for[...]
U.S. Senate Committee on Health,[...]
PREPARED REMARKS: Sanders Leads HELP Committee Hearing with Novo[...]
09/24/2024 | Press release | Distributed by Public on 09/24/2024 11:15
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact